ExploreBio

About

Portfolio · 2

Sentaur Biosciences

Pioneering Precision Therapeutics for Senescence Driven Diseases

1 round Latest: 2018-06

Pantheon Bioscience

Platform of Bacterial Defense Mechanism

1 round Latest: 2018-04

Investment activity

1 portfolio exit on record.

Q&A

What is ExploreBio's primary investment focus?

ExploreBio is a pre-seed investment vehicle focused on funding early-stage biotechnology companies and providing management services for proof-of-concept experiments in biotechnology.

Which investors partnered with Merck to establish ExploreBio?

ExploreBio was established as a partnership between Merck's strategic corporate venture capital arm, Arkin Holdings, Pontifax, and WuXi Apptec.

What is the typical investment amount per company for ExploreBio?

ExploreBio aims to invest between $1 million to $1.5 million per company.

How many investments does ExploreBio typically make per year?

ExploreBio aims to make up to four investments per year over a period of five years.

What is a notable exit for ExploreBio?

In February 2023, Immunorizon, a portfolio company of ExploreBio, was acquired by Purple Biotech for $100 million.

Which sectors does ExploreBio concentrate its investments in?

ExploreBio's investments are concentrated in the Health Tech & Life Sciences sector, with all three of its portfolio companies operating in this area.

Can you name some of ExploreBio's portfolio companies?

ExploreBio's portfolio includes Immunorizon, which focuses on T- and NK-cell Engagers for Cancer Therapy.

What is the role of Dr. Alon Lazarus at ExploreBio?

Dr. Alon Lazarus serves as the Chairman of ExploreBio.